Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 165

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Top Priorities for Cerebroprotective Studies—A Paradigm Shift: Report From STAIR XI

Open access
Lyden, Patrick, Buchan, Alastair, Boltze, Johannes, Fisher, Marc, Ansari, Saeed, Broderick, Joseph P, Campbell, Bruce CV, Chaisinanunkul, Napasri, Chen, Christopher, Grotta, James C, Haddad, Walid, Hareedy, Randa, Hill, Michael D, Houser, Gary, Jadhav, Ashutosh P, Khatri, Pooja, Kimberly, W Taylor, Koenig, James I, Korinek, William S, Landen, Jaren W, Lansberg, Maarten G, Latour, Lawrence L, Liebeskind, David S, Liston, Theodore E, Lynch, John, McGonigle, John, Mistry, Eva A, Mocco, J, Pryor, Kent E, Saver, Jeffrey L, Savitz, Sean I, Sheth, Kevin N, Solberg, Yoram, Vagal, Achala, Venkatasubramanian, Chitra, Ziogas, Nikolaos K · 2021 · Stroke

Abstract

Despite years of basic research and pioneering clinical work, ischemic stroke remains a major public health concern. Prior STAIR (Stroke Treatment Academic Industry Roundtable) conferences identified both failures of clinical trial design and failures in preclinical assessment in developing putative ischemic stroke treatments. At STAIR XI, participants in workshop no. 1 Top Priorities for Neuroprotection sought to redefine the neuroprotection paradigm and given the paucity of evidence underlying preclinical assessment, offer consensus-based recommendations. STAIR proposes the term brain cytoprotection or cerebroprotection to replace the term neuroprotection when the intention of an investigation is to demonstrate that a new, candidate treatment benefits the entire brain. Although “time is still brain,” tissue imaging techniques have been developed to identify patients with both predicted core injury and penumbral, salvageable brain tissue, regardless of time after stroke symptom onset. STAIR XI workshop participants called this imaging approach a tissue window to select patients for recanalization. Elements of the neurovascular unit show differential vulnerability evolving over differing time scales in different brain regions. STAIR proposes the term target window to suggest therapies that target the different elements of the neurovascular unit at different times. Based on contemporary principles of rigor and transparency, the workshop updated, revised, and enhanced the STAIR preclinical recommendations for developing new treatments in 2 phases: an exploratory qualification phase and a definitive validation phase. For new, putative treatments, investigators should carefully characterize the mechanism of action, the pharmacokinetics/pharmacodynamics, demonstrate target engagement, and confirm penetration through the blood-brain barrier. Before clinical trials, testing of candidate molecules in stroke models could proceed in a comprehensive manner using animals of both sexes and to include significant variables such as age and comorbid conditions. Comprehensive preclinical assessment might include multicenter, collaborative testing, for example, network trials. In the absence of a proven cerebroprotective agent to use as a gold standard, however, it remains speculative whether such comprehensive preclinical assessment can effectively predict clinical outcome.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/strokeaha.121.034947

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Cited by

See all 165

Metadata

Authors
Lyden, P., Buchan, A., Boltze, J., Fisher, M., Ansari, S., Broderick, J. P., Campbell, B. C., Chaisinanunkul, N., Chen, C., Grotta, J. C., Haddad, W., Hareedy, R., Hill, M. D., Houser, G., Jadhav, A. P., Khatri, P., Kimberly, W. T., Koenig, J. I., Korinek, W. S., Landen, J. W., Lansberg, M. G., Latour, L. L., Liebeskind, D. S., Liston, T. E., Lynch, J., McGonigle, J., Mistry, E. A., Mocco, J., Pryor, K. E., Saver, J. L., Savitz, S. I., Sheth, K. N., Solberg, Y., Vagal, A., Venkatasubramanian, C., & Ziogas, N. K.
Venue
Stroke
Published
2021-09
Volume
52
Issue
9
Pages
3063-3071
ISSN
  • 0039-2499 (ISSN-L)
  • 1524-4628
OpenAlex
W3185070319
Cited by
165
References
14
FWCI
15.93
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Top Priorities for Cerebroprotective Studies—A Paradigm Shift: Report From STAIR XI. https://app.cochat.ai/papers/10.1161/strokeaha.121.034947
The paper
Lyden, P., Buchan, A., Boltze, J., Fisher, M., Ansari, S., Broderick, J. P., Campbell, B. C., Chaisinanunkul, N., Chen, C., Grotta, J. C., Haddad, W., Hareedy, R., Hill, M. D., Houser, G., Jadhav, A. P., Khatri, P., Kimberly, W. T., Koenig, J. I., Korinek, W. S., . . . Ziogas, N. K. (2021). Top Priorities for Cerebroprotective Studies—A Paradigm Shift: Report From STAIR XI. Stroke. https://doi.org/10.1161/strokeaha.121.034947

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.